Aethlon Medical amended executive agreements so qualifying change-in-control severance and health-care payments will be made as lump sums after a change in control where existing holders retain no more than 50% of voting power. For investors, benefit amounts and eligibility conditions remain unchanged while payment timing becomes defined.
Key Highlights
- The amendments cover CEO and Chief Financial Officer James B. Frakes and Chief Medical Officer Steven P. LaRosa.
- Qualifying lump-sum payments are due on the first regular Payroll date after the applicable release becomes effective.
- Health-care continuation payments cannot later be reduced, forfeited or recouped because of new employer coverage or changed COBRA eligibility.
Executive Agreements Amended September 11
The amendments cover James B. Frakes and Steven P. LaRosa, M.D. The changes apply to Frakes, the chief executive officer and chief financial officer, and LaRosa, the chief medical officer. Frakes’ employment agreement dates to December 12, 2018, while LaRosa’s agreement dates to January 4, 2021; Frakes’ agreement was previously amended on November 7, 2023. The amendments do not change the amount or calculation of severance or health-care continuation payments, or the conditions that make either executive eligible for those benefits. Aethlon Medical (NASDAQ: AEMD) signed the report on September 15, 2026.
Payment Timing and Health-Care Protection
When the qualifying control transaction and termination or required resignation occur together, severance that would otherwise be paid in installments becomes payable in one amount. The payment is due on the first regular payroll date after the applicable release takes effect. Health-care continuation payments covering the applicable COBRA period also shift to one lump sum, and that amount remains unchanged if the executive later obtains group coverage through a new employer or stops qualifying for COBRA.
FAQs
Q: What changed in Aethlon Medical’s executive employment agreements?
A: Aethlon Medical changed qualifying change-in-control severance and health-care continuation payments from installments or direct coverage payments into single lump sums for two executives.
Q: What qualifies as a change in control under the amended terms?
A: The article does not specify what qualifies as a change in control under the amended terms. It refers only to a “qualifying control transaction” occurring together with termination or required resignation.
Q: When will Aethlon Medical make the lump-sum payments?
A: The lump-sum severance and health-care payments are due on the first regular payroll date after the applicable release becomes effective, subject to the agreement terms.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.